These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Need for caution in interpretation of Western Blot tests for HIV. Roy S; Portnoy J; Wainberg MA JAMA; 1987 Feb; 257(8):1047. PubMed ID: 3027425 [No Abstract] [Full Text] [Related]
23. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis. Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497 [TBL] [Abstract][Full Text] [Related]
25. Screening for HTLV-III antibodies: the relation between prevalence and positive predictive value and its social consequences. JAMA; 1985 Jun; 253(23):3395-8. PubMed ID: 2987557 [No Abstract] [Full Text] [Related]
26. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Jan; 34(1):1-5. PubMed ID: 2981394 [No Abstract] [Full Text] [Related]
27. [ELISA method for false positive reaction for the human immunodeficiency virus in a patient with alcoholic liver disease]. Clotet B; Grifol M; Bedini J; Foz M Med Clin (Barc); 1987 Feb; 88(8):347. PubMed ID: 3031394 [No Abstract] [Full Text] [Related]
28. More on HTLV-III antibody testing in New York City. N Engl J Med; 1986 May; 314(18):1190-1. PubMed ID: 3007988 [No Abstract] [Full Text] [Related]
29. Education is key to the battle against AIDS. Fisher EJ Mich Med; 1986 Mar; 85(3):98-9. PubMed ID: 3007946 [No Abstract] [Full Text] [Related]
30. False-positive results of confirmatory testing for antibody to HIV-I. Roy S; Fitz-Gibbon L; Spira B; Portnoy J; Wainberg MA CMAJ; 1987 Mar; 136(6):612-4. PubMed ID: 2880650 [No Abstract] [Full Text] [Related]
31. HTLV-3 produces a broad range of illness. Fisher EJ Mich Med; 1986 Mar; 85(3):96-8. PubMed ID: 3007945 [No Abstract] [Full Text] [Related]
32. Relation of HTLV-III seropositivity and lymphadenopathy. Jeffries E; Boyko WJ; Willoughby B; Constance PD; Wiggs B; O'Shaughnessy M; Sharp FR Can Med Assoc J; 1985 Jul; 133(2):111-2. PubMed ID: 2988732 [TBL] [Abstract][Full Text] [Related]
33. Status report on the acquired immunodeficiency syndrome. Human T-cell lymphotropic virus type III testing. Council on Scientific Affairs. JAMA; 1985 Sep; 254(10):1342-5. PubMed ID: 2991616 [No Abstract] [Full Text] [Related]
34. Priorities for HIV testing in developing countries? Colebunders R; Ndumbe P Lancet; 1993 Sep; 342(8871):601-2. PubMed ID: 8102727 [TBL] [Abstract][Full Text] [Related]
35. Lack of HTLV-I antibodies in Africans. Weiss RA; Cheingsong-Popov R; Clayden S; Pegram S; Tedder RS; Barzilai A; Rubenstein E Nature; 1986 Feb 27-Mar 5; 319(6056):794-5. PubMed ID: 3005874 [No Abstract] [Full Text] [Related]
36. [LAV/HTLV-III antibodies in blood and blood products]. Gürtler L; Eberle J; Deinhardt F Dtsch Med Wochenschr; 1985 Oct; 110(43):1639-40. PubMed ID: 2994977 [No Abstract] [Full Text] [Related]
37. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody prevalence in U.S. military recruit applicants. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Jul; 35(26):421-4. PubMed ID: 3014305 [No Abstract] [Full Text] [Related]
38. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Brun-Vezinet F; Rouzioux C; Barre-Sinoussi F; Klatzmann D; Saimot AG; Rozenbaum W; Christol D; Gluckmann JC; Montagnier L; Chermann JC Lancet; 1984 Jun; 1(8389):1253-6. PubMed ID: 6144973 [TBL] [Abstract][Full Text] [Related]
39. HTLV-III antibody testing in Spain. Nájera R; Echevarría JM; Varela JM; de Andrés R; de la Loma A Lancet; 1985 Oct; 2(8458):783. PubMed ID: 2864517 [No Abstract] [Full Text] [Related]